October 2018: The device used in this procedure (CyPass) has been withdrawn by the manufacturer Alcon, because of concerns about its long-term safety. Further details can be found in the Voluntary Field Safety Notice issued by Alcon. Surgeons are advised not to implant this device, to return any unused devices to Alcon and to consider reviewing any patients who have already been implanted with CyPass. Therefore NICE has decided to withdraw its guidance. NICE would consider whether to issue new guidance on ab interno supraciliary microstent insertion with phacoemulsification for primary open-angle glaucoma should evidence using an appropriately CE marked device become available.
Sorted by Relevance . | Sort by Date
- Last 3 years Remove Last 3 years filter
- Interventional procedures guidance Remove Interventional procedures guidance filter
- Public health guidelines Remove Public health guidelines filter
- Highly specialised technologies guidance Remove Highly specialised technologies guidance filter